Should all patients (pts) with advanced biliary cancers receive first-line treatment with cisplatin and gemcitabine (GC)?

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorMIRANDA, Vanessa Costa
dc.contributor.authorDIB-FARIA, Luiza
dc.contributor.authorBRAGHIROLI, Maria Ignez Freitas Melro
dc.contributor.authorSABBAGA, Jorge
dc.contributor.authorSARAGIOTTO, Daniel Fernandes
dc.contributor.authorCASTRO, Gilberto
dc.contributor.authorHOFF, Paulo M.
dc.contributor.authorRIECHELMANN, Rachel
dc.date.accessioned2014-07-18T20:48:52Z
dc.date.available2014-07-18T20:48:52Z
dc.date.issued2013
dc.description.conferencedateJAN 24-26, 2013
dc.description.conferencelocalSan Francisco, CA
dc.description.conferencenameGastrointestinal Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO)
dc.description.indexMEDLINE
dc.identifier.citationJOURNAL OF CLINICAL ONCOLOGY, v.31, n.4, suppl.S, 2013
dc.identifier.eissn1527-7755
dc.identifier.issn0732-183X
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/6307
dc.language.isoeng
dc.publisherAMER SOC CLINICAL ONCOLOGY
dc.relation.ispartofJournal of Clinical Oncology
dc.rightsopenAccess
dc.rights.holderCopyright AMER SOC CLINICAL ONCOLOGY
dc.subject.wosOncology
dc.titleShould all patients (pts) with advanced biliary cancers receive first-line treatment with cisplatin and gemcitabine (GC)?
dc.typeconferenceObject
dc.type.categorymeeting abstract
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.contributor.author-fmusphcVANESSA DA COSTA MIRANDA
hcfmusp.contributor.author-fmusphcLUIZA DIB BATISTA BUGIATO FARIA
hcfmusp.contributor.author-fmusphcMARIA IGNEZ FREITAS MELRO BRAGHIROLI
hcfmusp.contributor.author-fmusphcJORGE SABBAGA
hcfmusp.contributor.author-fmusphcDANIEL FERNANDES SARAGIOTTO
hcfmusp.contributor.author-fmusphcGILBERTO DE CASTRO JUNIOR
hcfmusp.contributor.author-fmusphcPAULO MARCELO GEHM HOFF
hcfmusp.contributor.author-fmusphcRACHEL SIMOES PIMENTA RIECHELMANN
hcfmusp.description.issue4
hcfmusp.description.issuesuppl S
hcfmusp.description.volume31
hcfmusp.origemWOS
hcfmusp.origem.wosWOS:000333679000241
hcfmusp.publisher.cityALEXANDRIA
hcfmusp.publisher.countryUSA
relation.isAuthorOfPublication60feea13-3afe-48c2-9198-2493431e9ba8
relation.isAuthorOfPublication552c782d-fdce-4c4a-9d2f-ba41f98c0931
relation.isAuthorOfPublicatione8f6ecfd-384c-4cd9-a8ef-c27fc574321a
relation.isAuthorOfPublication1bf00019-e507-43d3-942f-232b7aba8804
relation.isAuthorOfPublicationaf368258-3287-4b35-a42b-c25867f205e6
relation.isAuthorOfPublication0df25c0f-1337-424e-b0f7-41d0fccb51fc
relation.isAuthorOfPublication706efa42-09fc-4065-8330-9391f2cbe840
relation.isAuthorOfPublication7791870c-e5e2-4215-8209-16f0401d6ffe
relation.isAuthorOfPublication.latestForDiscovery552c782d-fdce-4c4a-9d2f-ba41f98c0931
Arquivos
Coleções
Comunicações em Eventos - FM/MDR
Comunicações em Eventos - HC/ICESP
Comunicações em Eventos - HC/InRad
Comunicações em Eventos - LIM/24